Skip to main content

Table 1 Baseline characteristics of the study populationa

From: Risk factors for mortality among malnourished HIV-infected adults eligible for antiretroviral therapy

Variable

Level

n (%)

N (%)

 

1815 (100)

Lusaka

 

1111 (61.2)

Age (years), median (IQR)

 

35 (29–41)

Female

 

900 (49.6)

BMI (kg/m2), median (IQR)

 

16.7 (15.6–17.5)

BMI <17 kg/m2

 

1074 (59.2)

CD4 count (cells/μl), median (IQR)

 

120 (51–211)

CD4 count group

> = 200

494 (27.2)

100–199

531 (29.3)

50–99

347 (19.1)

<50

443 (24.4)

Haemoglobin (g/L), median (IQR)

 

96 (80–111)

Haemoglobin groupb

Normal

177 (9.8)

Mild anaemia

285 (15.7)

Moderate anaemia

810 (44.6)

Severe anaemia

398 (21.9)

Missing

145 (8.0)

Phosphate <0.87 mmol/L

<0.87

196 (10.8)

Missing

51 (2.8)

Marital status

Married/Cohabiting

858 (47.3)

Widowed

203 (11.2)

Divorced-Separated

510 (28.1)

Single

243 (13.4)

Missing

1 (<0.1)

Occupation

Salaried

271 (14.9)

Self-employed

945 (52.1)

Housewife

183 (10.1)

Student

18 (1.0)

Unemployed

397 (21.9)

Missing

1 (<0.1)

Education

None

343 (18.9)

Primary

1045 (57.6)

Secondary

377 (20.8)

Tertiary

49 (2.7)

Missing

1 (<0.1)

TB treatment at baseline

 

304 (16.9)

Oedema at baseline

 

66 (3.6)

Initial ART regimen (% of 1474 patients who started ART)

AZT/3TC/EFV

135 (9.2)

AZT/FTC/NVP

236 (16.0)

TDF/FTC/EFV

816 (55.4)

TDF/FTC/NVP

64 (4.3)

Other

54 (3.7)

Missing

169 (11.5)

  1. aBMI body mass index, CI confidence interval, LNS lipid-based nutritional supplement without added vitamins and minerals, LNS-VM lipid nutritional supplement with added vitamins and minerals, AZT Zidovudine, 3TC Lamivudine, NVP nevirapine, TDF tenofovir, EFV efavirenz; FTC emtricitabine
  2. bHaemoglobin categories were selected based on usual nutritional cut-offs, not as defined for specific adverse events; adequate haemoglobin was defined as 130 g/L for men and 120 g/L for women; mild anaemia was 110 g/L to the adequate cut-off; moderate anaemia was 80–109 g/L; severe anaemia was < 80 g/L